Understanding Analyst Recommendations
When evaluating a stock for potential investment, it's crucial to grasp the company’s operational strengths and weaknesses, alongside its unique business aspects that differentiate it from competitors. Analysts on Wall Street often provide ratings for publicly traded companies, categorizing them as Buy, Hold, or Sell, which can offer insights for investors.
However, solely relying on analyst ratings may not be the wisest approach. Instead, these sentiments can serve as an additional reference, aiding in identifying investment opportunities or providing clarity regarding a company's financial health and prospects.
Here are three stocks currently receiving strong analyst support. Each has not only garnered attention but also experienced significant price increases as we approach the third quarter of 2025.
1. BlackSky Stock Surges on NGA Contract and Expansion Plans
First on our list is BlackSky Technology Inc (NYSE: BKSY), a firm specializing in intelligence and data analytics for governmental and corporate clients managing satellite operations. Recently, BlackSky's shares soared by 21% in the closing week of June 2025, largely attributed to their announcement regarding a notable four-year contract with the National Geospatial-Intelligence Agency valued at $24 million. This contract potentially opens the door for further opportunities for BlackSky down the line.
Moreover, they revealed plans for a new satellite initiative aimed at enhancing their existing high-frequency monitoring constellation for data collection. The first satellite launches are projected to occur in 2027, making it a critical development for investors interested in BlackSky and the broader space industry.
The company’s subscription-based geospatial intelligence service boasts a backlog exceeding $350 million, alongside impressive year-over-year sales growth surpassing 20%. As global conflicts intensify, BlackSky appears poised for additional growth. Nonetheless, analysts warn that despite the recent rise, BKSY may have limited upside, estimating only a 5% increase potential post-rally.
2. Core Scientific Grows Amid Acquisition Talks
Next up is Core Scientific Inc (NASDAQ: CORZ), a company engaged in cryptocurrency mining and hosting services, which may hold greater value through its robust data center infrastructure. Shares of Core Scientific surged approximately 49% in late June 2025, coinciding with the resurgence of acquisition discussions with AI hyperscaler CoreWeave.
Previously, CoreWeave made an unsolicited bid in 2024, proposing to purchase all outstanding shares of CORZ at $5.75 per share—an offer that Core Scientific deemed inadequate and subsequently rejected. Currently, with a market capitalization exceeding $5 billion, investors are keenly interested in whether CoreWeave will present a more favorable offer this time around.
Regardless of an acquisition, Core Scientific maintains a beneficial relationship with CoreWeave, having established various agreements following their past negotiations, including a notable deal to supply 200 MW of infrastructure to power CoreWeave’s high-performance computing operations.
By declining the earlier offer, Core Scientific may have successfully articulated its intrinsic value, potentially reassuring investors about its future potential.
3. Ambarella Experiences Rise Amid Sale Speculations
Lastly, we have Ambarella Inc (NASDAQ: AMBA), a company offering system-on-a-chip (SOC) solutions tailored for HD compression and image processing across diverse applications. A notable rally in Ambarella shares occurred in late June 2025, spurred by rumors suggesting the company might be pursuing a sale.
While these speculations should be approached with caution, they highlight a potential shift in the company's trajectory that investors should monitor as the third quarter approaches.
Beyond the sale speculations, there are solid reasons to consider investing in AMBA. The company's Edge AI SOCs are increasingly dominating a competitive market and command a premium price compared to other products. Should Ambarella enhance the proportion of its sales focused on this segment, it could solidify its path to recovery following a challenging year.
As analysts assess Ambarella, they express a favorable outlook with eight recommending Buys and four labeling it as a Hold. The general consensus suggests a promising 28% increase potential if the company continues on its current path.
Frequently Asked Questions
What are analyst ratings and why are they important?
Analyst ratings offer insights into a company’s expected performance based on comprehensive financial evaluations, serving as guidance for investors.
What recent news has affected BlackSky’s stock price?
BlackSky’s stock surged following a $24 million contract with the National Geospatial-Intelligence Agency, alongside plans for expanding its satellite projects.
What makes Core Scientific’s situation unique?
Core Scientific’s recent surge is tied to renewed acquisition talks with CoreWeave, indicating strong investor interest in the company’s infrastructure capabilities.
Is Ambarella considering a sale?
Ambarella has been the subject of rumors regarding a potential sale, which has led to increased speculation about its future direction.
What is the potential upside for these stocks?
Current analyst consensus suggests limited upside for BKSY, while Core Scientific and Ambarella respectively hint at promising growth amid their unique market positions.
